Product Images Breyanzi
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Breyanzi NDC 73153-900 by Juno Therapeutics, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure1
This appears to be a table/graph of some sort displaying Event Free Survival Probability for two different treatments (Standard Therapy and BREYANZI). The x-axis appears to be time in months, and the y-axis is not clear. However, there are numbers under each treatment heading indicating how many individuals were still at risk at different time points.*
Image - breyanzi 01
Image - breyanzi 02
Image - breyanzi 03
Image - breyanzi 04
Image - breyanzi 05
Image - breyanzi 06
Image - breyanzi 07
Image - breyanzi 08
Image - breyanzi 09
Image - breyanzi 10
PRINCIPAL DISPLAY PANEL - Kit Carton - breyanzi 11
Lisocabtagene maraleucel is a prescription medication with the brand name Breyanzi, meant for autologous and intravenous use only. This medication contains CAR-positive viable T cells and DMSO 7.5% /v. Each of the 1104 single-dose vials contains 1.5 t070 X 0% CAR-positive viable T cells/mL. It should be stored at -130°C and not filtered or irradiated. The manufacturer is Juno Therapeutics, a Bristol-Myers Squibb company based in Bothell, WA, and the medicine is not evaluated for infectious substances. The text also provides information regarding its dosage, shipment details, and other instructions.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.